Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
@WalmartLabs, part of Wal-Mart Stores Inc.'s social media division, has acquired another shopping app, Luvocracy. Wal-Mart hasn't disclosed terms of the deal. Founded in 2011, Luvocracy has since been surpassed by Pinterest, another social shopping platform.
Beebe will be bringing drones to school this fall. The school district will offer a drones class after ninth- and 10th-grade Principal Mike Tarkington got the idea for starting one while watching an episode of "60 Minutes" about them in March.
The partnership with Verizon will enable Aurora clients to use the Verizon Wireless network to power their digital signage and eliminate the need to run internal cables.
Gamers can expect to see the free Overwatch combat gaming app in the iTunes store within a couple of weeks, Overwatch CEO Josh Moody told his 1 Million Cups audience Wednesday in Little Rock.